Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms (Q21256691)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

18 July 2021

Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

22 October 2019

1 reference

based on heuristic

inferred from title

prostatic hypertrophy

1 reference

22 October 2020

1 reference

22 October 2020

lower urinary tract symptoms

1 reference

18 July 2021

1 reference

PubMed publication ID

1 reference

PubMed publication ID

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

Simone Carradori

2

object named as

Simone Carradori

author given names

Simone

author last names

Carradori

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Cosimo De Nunzio

6

object named as

Cosimo De Nunzio

author given names

Cosimo

author last names

De Nunzio

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Giovanni Battista Di Pierro

4

object named as

Giovanni Battista Di Pierro

author given names

Giovanni Battista

author last names

Di Pierro

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Celeste De Monte

1

author given names

Celeste

author last names

De Monte

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Arianna Granese

3

author given names

Arianna

author last names

Granese

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Costantino Leonardo

5

author given names

Costantino

author last names

Leonardo

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

0 references

publication date

11 August 2014

6 references

Europe PubMed Central

PubMed publication ID

21 June 2017

25 June 2019

6 August 2019

22 October 2019

22 October 2020

18 July 2021

6 references

25 June 2019

6 August 2019

22 October 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

22 October 2020

18 July 2021

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

0 references

63

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

copyright license

Creative Commons Attribution 2.0 Generic

5 references

Europe PubMed Central

25 June 2019

Europe PubMed Central

6 August 2019

Europe PubMed Central

22 October 2019

Europe PubMed Central

22 October 2020

Europe PubMed Central

18 July 2021

copyright status

0 references

Serenoa repens for benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

19 March 2017

Applications of supercritical fluid extraction (SFE) of palm oil and oil from natural sources

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

19 March 2017

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

19 March 2017

Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

19 March 2017

NMR methodologies in the analysis of blueberries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Lipidosterolic extract of serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Application of ionic liquid for extraction and separation of bioactive compounds from plants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Isolation of essential oil from different plants and herbs by supercritical fluid extraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

The correlation between metabolic syndrome and prostatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Serenoa repens extract in the treatment of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Pressurized liquid extraction as a green approach in food and herbal plants extraction: A review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Microwave-assisted extractions of active ingredients from plants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Enzyme-assisted extraction of bioactives from plants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Treatment options for benign prostatic hyperplasia in older men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Phytotherapy in the management of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

12 September 2017

Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

27 September 2017

Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

27 September 2017

Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

27 September 2017

Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

27 September 2017

Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

30 May 2018

Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Development of saw palmetto (Serenoa repens) fruit and extract standard reference materials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Isolation and pharmacological characterization of fatty acids from saw palmetto extract

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): effects on rat prostate contractility

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

A Widespread Population Study of Actual Medical Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia Across Europe and Beyond Official Clinical Guidelines

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-14-63

21 January 2018

Tolerability and toxicity of lipidosterolic extract of American dwarf palm Serenoa repens in Wistar rats: well-known extract, new insight

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4136420

29 November 2018

Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25112532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25112532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2490-14-63

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Dimensions Publication ID

0 references

release_67rchamrgvgbvbx6zuwcpz7ktq

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25112532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21256691&oldid=2176718021"